AbstractOsteoprotegerin (OPG) is a decoy receptor for receptor activator of nuclear factor κB ligand (RANKL), an inducer of osteoclastogenesis via its receptor RANK. We recently demonstrated that OPG also exerts a direct effect in osteoclasts by regulating protease expression. Herein, we showed that OPG-induced pro-matrix metalloproteinase-9 activity was abolished by ras/MAPK inhibitors in purified osteoclasts. OPG induced the phosphorylation of p38 and ERK1/2 in RAW264.7 cells. Only p38 activation was totally abolished by a blocking anti-RANKL antibody or an excess of RANKL. Surface plasmon resonance experiments revealed that RANK, RANKL and OPG are able to form a tertiary complex. These results suggested a potential formation of a tertiar...
AbstractBackgroundOsteosarcoma (OS) is an aggressive and often fatal cancer that afflicts over 1000 ...
Osteoblast-osteoclast coordination is critical in the maintenance of skeletal integrity The modulati...
Primary bone tumors and cancers that metastasize to bone require osteoclastic activity to release tu...
AbstractOsteoprotegerin (OPG) is a decoy receptor for receptor activator of nuclear factor κB ligand...
SummaryOsteoprotegerin (OPG) and receptor activator of nuclear factor κB (RANK) are members of the t...
The remodeling process results from the action of the tissue-forming osteoblasts and the tissue-reso...
[[abstract]]The interaction between receptor activator of nuclear factor κB ligand (RANKL) and osteo...
[[abstract]]The interaction between receptor activator of nuclear factor κB ligand (RANKL) and osteo...
Pathological osteolyses are considered a consequence of a disturbance in the mechanisms that govern ...
Osteoprotegerin (OPG)–receptor activator of nuclear factor-κB (RANK) and RANK ligand (RANKL) have be...
Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, is known to inhib...
Various osteotropic agents that influence bone resorption are known to act primarily via osteoblasts...
International audienceThe emergence of the molecular triad osteoprotegerin (OPG)/Receptor Activator ...
Receptor activator of NF-kB Ligand (RANKL) is an essential requirement for osteoclastogenesis and it...
Receptor activator of NF-kB Ligand (RANKL) is an essential requirement for osteoclastogenesis and it...
AbstractBackgroundOsteosarcoma (OS) is an aggressive and often fatal cancer that afflicts over 1000 ...
Osteoblast-osteoclast coordination is critical in the maintenance of skeletal integrity The modulati...
Primary bone tumors and cancers that metastasize to bone require osteoclastic activity to release tu...
AbstractOsteoprotegerin (OPG) is a decoy receptor for receptor activator of nuclear factor κB ligand...
SummaryOsteoprotegerin (OPG) and receptor activator of nuclear factor κB (RANK) are members of the t...
The remodeling process results from the action of the tissue-forming osteoblasts and the tissue-reso...
[[abstract]]The interaction between receptor activator of nuclear factor κB ligand (RANKL) and osteo...
[[abstract]]The interaction between receptor activator of nuclear factor κB ligand (RANKL) and osteo...
Pathological osteolyses are considered a consequence of a disturbance in the mechanisms that govern ...
Osteoprotegerin (OPG)–receptor activator of nuclear factor-κB (RANK) and RANK ligand (RANKL) have be...
Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, is known to inhib...
Various osteotropic agents that influence bone resorption are known to act primarily via osteoblasts...
International audienceThe emergence of the molecular triad osteoprotegerin (OPG)/Receptor Activator ...
Receptor activator of NF-kB Ligand (RANKL) is an essential requirement for osteoclastogenesis and it...
Receptor activator of NF-kB Ligand (RANKL) is an essential requirement for osteoclastogenesis and it...
AbstractBackgroundOsteosarcoma (OS) is an aggressive and often fatal cancer that afflicts over 1000 ...
Osteoblast-osteoclast coordination is critical in the maintenance of skeletal integrity The modulati...
Primary bone tumors and cancers that metastasize to bone require osteoclastic activity to release tu...